Ginkgo Bioworks Stock Is Rallying Tuesday: Here's Why
Ginkgo Bioworks Stock Is Rallying Tuesday: Here's Why
Ginkgo Bioworks Holdings Inc (NYSE:DNA) shares are surging Tuesday after the company announced the launch of its new protein large language model (LLM) built on Google Cloud.
Ginkgo Bioworks Holdings Inc (紐交所:DNA)股票在週二大漲，該公司宣佈推出了在Google Cloud上建立的新的大蛋白語言模型（LLM）.
What Happened: Ginkgo Bioworks has introduced a pair of new offerings aimed at making it easier for pharmaceutical and biotech companies to develop new medicines.
發生了什麼：Ginkgo Bioworks推出了一對新產品，旨在爲製藥和生物技術公司開發新藥物提供便利。
The company's protein large language model, built in collaboration with Alphabet Inc's (NASDAQ:GOOG) Google Cloud Consulting, will give individual researchers and enterprise companies the ability to develop medicines with insights from Ginkgo's private data.
該公司與Alphabet Inc（納斯達克：GOOG）旗下的Google Cloud Consulting合作開發的大蛋白語言模型將使獨立研究者和企業公司能夠從Ginkgo的私有數據中獲得開發藥物的見解。
"Ginkgo's new protein LLM and open API mark a major step forward in making advanced AI tools accessible for drug discovery and biological research," said Chris Sakalosky, vice president of strategic industries at Google Cloud.
Google Cloud戰略行業副總裁Chris Sakalosky表示:"Ginkgo的新的蛋白LLm和開放式API在推動先進的AI工具在藥物發現和生物研究方面取得了重大進展。"
Ginkgo Bioworks also announced the launch of its model API, designed to deliver biological AI models directly to machine learning scientists. The company noted that the new API is publicly available on its website as of Tuesday.
Ginkgo Bioworks還宣佈推出其模型API，旨在直接向機器學習科學家提供生物AI模型。公司指出，這個新的API 從週二起在其網站上公開提供。
"I'm excited to see how the community builds on top of these models and our API. AA-0 is the first model we have released trained on Ginkgo's proprietary data – we're opening it to data scientists and bioinformaticians so they can build new models and applications on top," said Jason Kelly, CEO of Ginkgo Bioworks.
Ginkgo Bioworks的CEO Jason Kelly表示:"我很興奮看到社區如何基於這些模型和我們的API進行開發。AA-0是我們首次發佈的一個基於Ginkgo專有數據訓練的模型，我們將其開放給數據科學家和生物信息學家，以便他們可以在此基礎上構建新的模型和應用程序。"
"We believe that the low cost for tokens and our other customer-friendly terms, like the lack of royalties, and our commitment to not re-use customer data, will allow users to build tools like iterative protein design programs that call our protein generation API or to use our embedding API to compute features for a clustering algorithm."
"我們相信，令牌的低成本和其他用戶友好的條款，如不支付版稅的承諾以及我們不重複使用客戶數據，將使用戶能夠構建諸如調用我們的蛋白生成API的迭代蛋白設計程序或使用嵌入式API爲聚類算法計算特徵的工具。"
Ginkgo said it plans to roll out more models and expand API capabilities over the next year as it works towards building a robust suite of tools to help biotech and pharmaceutical companies solve complex problems.
據Ginkgo表示，該公司計劃在未來一年推出更多模型，並擴展API的功能，以建立強大的工具套件，幫助生物技術和製藥公司解決複雜問題。
DNA Price Action: Ginkgo Bioworks shares were up 16.7% at $7.26 at the time of publication, according to Benzinga Pro.
DNA價格走勢：根據Benzinga Pro的數據，在發佈時，Ginkgo Bioworks的股價上漲16.7%，達到7.26美元。
Photo: Shutterstock.
照片：shutterstock。
譯文內容由第三人軟體翻譯。